Found 8 matching trials
The Immunogenicity and Safety Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB001
EARLY_PHASE1The goal of this clinical trial is to assess the immunogenicity and safety ...
Location
Chengdu Xinhua Hospital Affiliated to North Sichuan Medical College
Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older
PHASE3This is an international multicenter clinical trial, which is planned to be...
Location
Bishan District People's Hospital,Chongqing
Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above
PHASE2This is a randomized, blinded, positive-controlled study to evaluate the im...
Location
Jiangsu Provincial Center for Disease Control and Prevention
The Phase Ⅱ/Ⅲ Trial of LYB001
PHASE2The study will be conducted in two phases using a randomized, double-blind,...
Location
Multiple Locations
Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above
PHASE3A total of 1200 people aged 18 years and older who have completed two or th...
Location
Hubei Provincial Center for Disease Control and Prevention
Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above
PHASE1This is a randomized, blinded, positive-controlled study to evaluate the sa...
Location
Jiangsu Provincial Center for Disease Control and Prevention
A Phase Ⅰ Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine LYB001
PHASE1This is a randomized, double-blind, placebo-controlled Phase Ⅰ trial in hea...
Location
Multiple Locations
Phase Ⅱ and Ⅲ Trial of a SARS-CoV-2 Vaccine LYB001
PHASE2The phase Ⅱ trial adopts a randomized, double-blind, placebo-controlled des...
Location
Multiple Locations